Evidence map›Paper›PMID 39480072›Full record

ArticleAntimicrobial agents and chemotherapy2024

Exploration of novel mechanisms of azole resistance in

Jizhou Li, Danielle Brandalise, Alix T Coste, Dominique Sanglard, Frederic Lamoth

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Observational
  3. Deciphering the multidrug resistance paradigm inAntimicrobial agents and chemotherapy · 2026
    Review
  4. Flavonoids as a Potential Antifungal Alternative AgainstJournal of fungi (Basel, Switzerland) · 2026
    Article
  5. Article
  6. Review
  7. Resistance gene mutations and phylogenetic relationships inFrontiers in cellular and infection microbiology · 2026
    Article
  8. Review
  9. Review
  10. Identification, antifungal resistance, and genomic characterization of a singleFrontiers in cellular and infection microbiology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jizhou LiInstitute of Microbiology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.ORCID 0000-0001-6007-2661
Danielle BrandaliseInstitute of Microbiology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Alix T CosteInstitute of Microbiology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Dominique SanglardInstitute of Microbiology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.ORCID 0000-0002-5244-4178
Frederic LamothInstitute of Microbiology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.ORCID 0000-0002-1023-5597

Funding

Fondation Santos-Suarez pour la Recherche Médicale (Santos-Suarez Foundation for Medical Research)Swiss National Science Foundation 310030_192611
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antifungal AgentsAzolesCandida aurisDrug Resistance, FungalFluconazoleFungal ProteinsMicrobial Sensitivity TestsCandidiasisCytochrome P-450 Enzyme SystemHumansMutationTranscription FactorsAntifungal AgentsAzolesCytochrome P-450 Enzyme SystemFluconazoleFungal ProteinsTranscription Factorsdrug transportersfluconazolemitochondriatranscription factors

Identifiers

PMID39480072
PMCPMC11619343

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.